Today’s edition of quick hits:
* FDA: “Covid-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don’t work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health regulators said Monday.”
* In related news: “Pfizer and BioNTech announced Tuesday that they have started a clinical trial testing a modified Covid-19 vaccine to protect against the supercontagious omicron variant of the coronavirus.”
* In geopolitical terms, this is one of the day’s biggest developments: “The Biden Administration announced on Tuesday that it was working with gas and crude oil suppliers from the Middle East, North Africa and Asia to bolster supplies to Europe in coming weeks, in an effort to blunt the threat that Russia could cut off fuel shipments in the escalating conflict over Ukraine.”
* A huge announcement from GM: “In a big win for Michigan, General Motors will invest $7 billion in four manufacturing facilities, making the state the ‘hub’ of electric vehicle development and manufacturing. GM said Tuesday it will spend $2.6 billion to build a new battery factory in the Lansing area and $4 billion to convert its existing factory in Orion Township to make electric pickups. It will also spend about half a billion dollars to make upgrades to its two existing vehicle assembly plants in Lansing.”
* A worthwhile White House initiative: “Pharmacies and health centers around the country have begun distributing the first of the 400 million N95 masks the White House is sending out to combat the fast-spreading omicron variant of the coronavirus.”








